The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.
Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
José Inácio Faria MEP, Group of the European People’s Party (Christian Democrats) explains the approach of taking advantage of the EU scale to improve national healthcare systems.
Romola Davenport and Richard Smith, Cambridge Group for the History of Population and Social Structure, Department of Geography, University of Cambridge, explore the history and evolution of public health, in this article.
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
Jon Ander Gómez and Monica Caballero, DeepHealth Technical Manager and Project Coordinator, lift the lid on an exciting project that concerns deep-learning and high performance computing to boost biomedical applications for health.
Thanks to the economic and social progress we have made, life expectancy has increased. However, ageing often comes with health issues and restricted mobility – a challenge not only for the elderly and their families but also for society.
Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explores the emerging role of tumour necrosis factor receptor-associated factor 6 including the challenges and opportunities in this vein.
BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.
Of the digitisation projects ongoing at St Helens and Knowsley Teaching Hospitals (STHK) NHS Trust, electronic prescribing and medicines administration (EPMA) represents the biggest step forward for patient safety.
Paola Testori Coggi, Former Director General for Health and Consumers, European Commission speaks to Open Access Government about her work here on defending investments in public health.
SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, explains how they are recognised internationally as a hub of process innovation and advanced manufacturing for the pharmaceutical sector.
The NHS reports that 1 in 5 women in the UK are currently affected by PCOS, but what do we really know about the condition? It’s imperative that women have a clear understanding of their reproductive health. here, we explain everything you need to know about PCOS.
